home · filing · 0001079973-22-001411
8-K
filed November 10, 2022, 6:59 PM ET
ticker CFOR
CIK 0001293818
earnings
confidence high
sentiment negative
materiality 0.75
OpGen Q3 revenue drops to $0.4M from $1.2M; net loss $14.1M; cash down to $10.3M
CapForce Inc.
2022-Q3 EPS reported
-$0.57
revenue $1,885,663
Total revenue $0.4M for Q3 2022 vs $1.2M in Q3 2021; net loss $14.1M ($0.30/sh) vs $6.1M loss.
Cash and equivalents $10.3M as of Sept 30, 2022, down from $36.1M at Dec 31, 2021.
Elected Yvonne Schlaeppi as independent director; she brings legal, governance, life sciences experience.
Completed enrollment of >1,800 samples for Unyvero UTI trial; anticipates FDA submission in 2023.
Full-year 2022 revenue guidance $2.5M to $3M; exploring additional financing and strategic alternatives.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Yvonne Schlaeppi
Director
CapForce Inc.
Effective 2022-11-08
Filed November 10, 2022, 6:59 PM ET
On November 8, 2022, the Board of Directors of the Company (the “Board”) elected Yvonne Schlaeppi as a member of its Board of Directors.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
CapForce Inc. reported Full Year 2022 results: revenue approximately $2.5 to $3 million. Guidance initiated.
Period Full Year 2022
Revenue approximately $2.5 to $3 million
Guidance initiated
Result guidance update
Exact text from the filing
Overall, 2022 revenue in a range of approximately $2.5 to $3 million from products and services as well as collaboration business globally.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Yvonne Schlaeppi was elected as Director at CapForce Inc..
Action elected
Role Director
Exact text from the filing
On November 8, 2022, the Board of Directors of the Company (the “Board”) elected Yvonne Schlaeppi as a member of its Board of Directors.
View on SEC.gov
Source: SEC EDGAR
accession 0001079973-22-001411
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.